Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of obesity. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://lucypdly885955.theblogfairy.com/37916952/semaglutide-a-potential-solution-for-diabetes